2004
DOI: 10.1016/j.yjmcc.2003.12.008
|View full text |Cite
|
Sign up to set email alerts
|

NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

7
100
2
5

Year Published

2004
2004
2022
2022

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 137 publications
(114 citation statements)
references
References 44 publications
7
100
2
5
Order By: Relevance
“…*Significantly (P < 0.05) different from baseline. isoforms observed in this study 10 were abolished by PD 098059 pretreatment. Another adenosine A 1 /A 2 receptor agonist (AMP579) also exerted protective effects during reperfusion in rabbits 15 via an Erk1/2-dependent mechanism.…”
Section: Discussionsupporting
confidence: 57%
See 4 more Smart Citations
“…*Significantly (P < 0.05) different from baseline. isoforms observed in this study 10 were abolished by PD 098059 pretreatment. Another adenosine A 1 /A 2 receptor agonist (AMP579) also exerted protective effects during reperfusion in rabbits 15 via an Erk1/2-dependent mechanism.…”
Section: Discussionsupporting
confidence: 57%
“…16 The adenosine A 1 /A 2 subtype receptor agonist 5'-(N-ethylcardoxamido) adenosine (NECA) and bradykinin administered during early reperfusion reduced infarct size by activation of Erk1/2 in isolated rabbit hearts. 10 N-ethylcardoxamido adenosine and bradykinin-induced phosphorylation of Erk1/2 FIGURE 3 Schematic illustration of potential sites of action of isoflurane on cardioprotective signaling during early reperfusion. G protein-coupled receptor ligands, insulin, statins, growth factors, and volatile anesthetics activate parallel phosphoinositol-3-kinase (PI3K) or extracellular signal regulated kinase (Erk1/2) cascades to produce protection.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations